Tanezumab (Pfizer) targets nerve growth factor IgG; the humanized mAbs is in Phase III trials for osteoarthritis pain relief...
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|